Try our Advanced Search for more refined results
Life Sciences - April, 2022
313 articles
- 1 Split, 3 Vehicles: High Court's Paths To Bridging FCA Divide
- Theranos Investor Says Balwani Told Him Science Was Solid
- Fed. Circ. Says Skepticism Can't Save Robotic Surgery Patent
- 4th Circ. Sides With W.Va. Limit On Attys' Medication Case Ads
- Purdue Tells 2nd Circ. 30 Years Of Precedent Back Ch. 11 Plan
- Pharma Co. Sued For $12M For Underpaying Board Chair
- Ski Mogul Gets 5 Years In 'Massive' Vermont EB-5 Fraud Case
- Ranbaxy Buyers' $485M Deal In Generics MDL Gets Initial Nod
- Courts Are Unsettled On Obviousness-Type Double Patenting
- Sanitizer Co. Ch. 11 Loan Called Attempt To Dodge Liability
- Foley & Mansfield Adds Litigation Partner In New Orleans
- Goodwin Procter Adds Davis Polk Capital Markets Pro
- Law Firms Topple J&J Subpoenas For Talc Media Info
- MORE Act's Possible Impact On State-Licensed Cannabis Cos.
- Vaccine Maker's Upsized Offering Leads Pair Of Biotech IPOs
- Health Hires: Akin Gump, Katten
- Real Estate Rumors: Easton Group, WS Development, RFR
- Associates, Look Beyond Money In Assessing Lateral Offers
- UK Litigation Roundup: Here's What You Missed In London
- Medline Must Face Rival's Trimmed Misinformation Suit
- Feds Beat NJ Doctor's FOIA Suit Over DNA Docs
- Judge Slashes Suit Claiming MabVax Execs Duped Investors
- Turkey Takes WTO Loss On Drug Rules To Arbitration
- Prenatal Test Maker Faces Investor Suit Over False Positives
- Air Force Officer Can Seek Class Status In Vax Mandate Suit
- Restoring America Invents Act Should Not Do The Opposite
- ER Chief Says Opioid Crisis Feels 'Hopeless' At SF Bellwether
- Feds Push Back On Bid For $1.9M Fees In GMO Salmon Suit
- Bausch & Lomb Spinoff IPO Could Raise $788M
- FDA Proposes Menthol Ban In Cigarettes
- 2nd Circ. Doubts Ex-Shkreli Atty Can Keep BigLaw Nest Egg
- Preventing Impermissible Client Solicitation After ABA Opinion
- 4 Issues To Watch As Adult-Use Cannabis Sales Begin In NJ
- Hedge Fund Priest Seeks New Trial After 'Trivial' SEC Win
- Amgen Plans To Challenge Latest $7.1B Tax Bill From IRS
- COVID-19 Cases Won't Stop SF's Opioid Bellwether Trial
- Walgreens Opioid Inaction Preceded Fla. Shutdown, Jury Told
- Balwani Recruited His Dermatologist As Lab Chief, Jury Told
- 'Overheated Hyperbole'? Opioid Atty Gets Fiery In SF Trial
- 1st Circ. OKs Hospital's Denial Of Vax Mandate Exemptions
- Ark. Consulting Firm Wants Out Of Medical Pot Biz Suit
- Alcon Sues Over Alleged Eye Drop Patent Infringement
- Coloplast Hit With $2.5M Verdict In Pelvic Mesh Trial
- What FDA Expects From Medical Device Cybersecurity Efforts
- Purdue Ch. 11 Injunction Extended Pending 2nd Circ. Decision
- Real Estate Rumors: RRD International, Calta, Starbucks
- Teligent Gets Ch. 11 Disclosure, Voting Plans OK'd In Del.
- Express Scripts Wants Departing Attys To Aid Acthar Dispute
- CMA Gets Post-Brexit Cancer Drug Pricing Pact From Aspen
- Lessons On Avoiding E-Discovery Violations And Sanctions
- Buchanan Ingersoll Wants $1.9M From Ex-Client's Settlement
- 'Small Fish' Drugmakers Blame Purdue In SF Opioid Trial
- J&J Says Counterfeit Ring Selling 'Dangerous' HIV Meds
- Orrin Hatch's IP Influence Goes Far Beyond Generic Drugs
- AstraZeneca Sues Mylan Over Fresh Asthma Drug Patent
- Balwani Jurors Can Hear If Investors Knew He Dated Holmes
- States In Shkreli FTC Trial Told To Redo $2.2M Atty Fee Ask
- Week In Bankruptcy: InfoWars' Shaky Start, Releases Still Roil
- 2nd Circ. Affirms Shire Sanctions In Pharma IP Fight
- Allergy Co. Claims Trimmed As Untimely In Conspiracy Suit
- Juul Faces More Suits Over Marketing Vapes As 'Safe'
- A Quiet Change At The USPTO Creates A 2-Tier Exam Process
- Takeaways On The New Antitrust Scrutiny In Health Care
- Hospital Beats Title VII Claim Over Gender-Affirming Care
- FDA Allows NJOY E-Cigs To Stay On Market
- Counsel Leadership Fight Looms In Pharma Co. Pay Suit
- Fla. Doc Can't Dodge Fraudulent Fentanyl Fight With Feds
- Collaborative Tech Will Dictate Future Law Firm Success
- Philips Subpoenaed By DOJ Over Sleep Apnea Device Recall
- SF Opens Key Opioid Bellwether Trial Vowing To Reveal 'Lies'
- Health Network's Virus Coverage Suit Sent To State Court
- US Trustee Calls Teligent Ch. 11 Plan Releases 'Baffling'
- Shkreli Poses 'Serious Risk' Without Pharma Ban, Judge Says
- HHS Urged To Lower Drug Costs By 'Breaking Patent Barriers'
- 2nd Circ. Says Charge, Not Conviction, Enough To Void Bail
- $200M Shipping Accident Award Hasn't Been Paid, Co. Says
- Cannabis REIT Is A 'Marijuana Bank' In Disguise, Suit Says
- Chamber Backs Vitamin C Importers' Renewed High Court Bid
- Justices Won't Review Fed. Circ. Ruling Axing Drug Dosing IP
- Novartis Wants Rival's Atty Booted From MS Drug Patent Suit
- Catching Up With Delaware's Chancery Court
- How To Effectively Prepare A Witness For Remote Testimony
- Latham-Led Vax Developer Launches Plans For $175M IPO
- Mallinckrodt Creditors Can't Get Ch. 11 Plan Halted
- Law360's 2022 Life Sciences Editorial Advisory Board
- Ranbaxy Buyers Seek OK On $485M Deal In Generics MDL
- Balwani Never Told Theranos Lab Director To Lie, Jury Hears
- COVID Illness Delays Bard, AngioDynamics Patent Trial In Del.
- Cannabis Bill Roundup: SC Lawmaker Pitches '420 Day'
- Clinics Accused Of HIV Drug Scam Protest Asset Freeze
- Ex-Ermi Compliance Chief Loses Whistleblower Suit, For Now
- Officer Says Air Force Can't Stay Vaccine Mandate Suit
- Windy City Shuffle: Crowell & Moring, Benesch, Ballard Spahr
- A Crucial Element In Patent Prosecution: Examiner Experience
- Health Hires: Ichnos Sciences, Turnstone Biologics
- Expert's Sexual Abuse Conviction Jolts Formula Tariff Case
- As Cyber Risks Surge, Remember Attorneys' Ethical Duties
- Fla. Commissioner Sues DOJ Over Pot Patients' Gun Rights
- 'Our Heads Were Spinning': Trial Atty Explains Rare Strategy
- Environmental Coverage Disputes Continue Evolution In 2022
- UK Litigation Roundup: Here's What You Missed In London
- Bellwether By The Bay: Key Details As SF Opioid Trial Looms
- Calif. Judge Sends Aetna's HIV Drug Suit To State Court
- IP Forecast: 6th Circ. To Eye Seed Biz's $7M Trade Secret Win
- Disqualified Endo Judge Defends Facebook Posts On Opioids
- Ionis Pharmaceuticals Sued In Del. For Director Pay Docs
- US Trade Rep Downplays Reports Of COVID IP Waiver Deal
- Telemed Doctor Charged In $10M Prescription Fraud Scheme
- FibroGen Board, Officers Sued In Del. Over Drug Missteps
- New USPTO Head Sets Sights On Diversity, Arthrex Guidelines
- Former Biz Adviser Gets 18 Months For EB-5 Fraud Scheme
- Judge Admits 'Inexcusable' Error In Atty's SEC Fraud Trial
- Rethinking E-Discovery Readiness Amid Rise Of Collab Tools
- Fla. Court Reverses $3.25M In Damages In Engles Case
- Endo Reaches $10M Deal With SF Ahead Of Opioid Trial
- Balwani Can't Portray Gov't Witness As 'Bad Lab Director'
- Blackstone Wraps Up $1.6B Life Sciences Fund
- Ovarian Cancer Patients Want Louder Voice In J&J Unit Ch. 11
- NYC Workers Hit City With Vax Requirement Suit
- Akanda Buys Canadian Cannabis Co. Subsidiary For $28M
- Calif. Medical Cannabis Co. Loses Pot Farm Search Fight
- Health Cos. Could See More Conference Enforcement Risk
- GAO Won't Revisit View On Late Electronic Bids In FDA Case
- Troutman Pepper Adds 2 Corporate Partners From Cooley
- Wilson Sonsini Adds Goodwin M&A Expert In LA Office
- Alkermes, Janssen Enter Arbitration Over NanoCrystal Tech
- Embracing ESG: Uber Counsel Talks Safety Standards
- Endo Wins Reversal Of Opioid Default And Judge Is DQ'd
- Prospectively Appointing Jackson To High Court Is Unlawful
- Theranos Never Fulfilled Finger Stick Test Promise, Jury Hears
- Arbor, Lupin End IP Suit Over Planned Blood Pressure Generic
- Alabama AG Ends Opioid Holdout With Deals Worth $276M
- Ex-Attys For Dermagraft Whistleblower Nab $6M Fee Award
- Fed. Circ. Mulls UMass Bid To Revive L'Oreal Skincare IP Suit
- DOJ Says Teva, Like Glenmark, Can't Get Grand Jury Docs
- SEC Gets Consent Win For CEO's COVID-19 Product Claims
- Eye Docs Say Recordkeeper Hid Ransomware Attack Outages
- Injectable Drug Dropped From $375M Merger To Assuage FTC
- Strategies To Help Close IP Law's Long-Standing Gender Gap
- Wachtell, Goodwin Rep In Regeneron's $250M Biopharma Buy
- Calif. County Beats Couple's Pot License Denial Challenge
- Norton Rose Adds Brussels Antitrust Pro From Covington
- Gibson Dunn Adds Biopharma IP Partner From Ropes & Gray
- Ex-Aegerion Rep Owes $1.6M To Fraud Victims, Feds Say
- Johns Hopkins Beats $1B Guatemalan Syphilis Study Suit
- New Court Takes The Wheel In NY's Vast Opioid Litigation
- Conn. Atty Can't Redo Trial Over Alleged Jury Talk, SEC Says
- Conformis Asks 1st Circ. To Save Knee Implant Coverage Row
- ACLU Says Nevada Pot Schedule I Status Unconstitutional
- Ark. Medical Pot Regulator Can't Exit Suit Over License Denial
- Big Cos. Shouldn't Cry 'Settlement Pressure' To Justify Appeal
- Consumers Win Cert. Of Dietary Supplement False Ad Class
- Justices Want SG's Take On Enablement In Antibody IP Fight
- The Rise Of Cannabis Mobile Commerce
- Catching Up With Delaware's Chancery Court
- Tela Bio Hires Life Sciences Atty As 1st GC
- Latham, Davis Polk Steer ArchiMed's $1.2B Natus Medical Deal
- Opioid Trial Gamble Pays Off For W.Va. In $99M Deal With J&J
- CR Bard Hit With $250K Verdict In 2nd Hernia Mesh Bellwether
- Jury Told Balwani Provided Theranos' Investor Financial Data
- Roche Ruling Highlights High Bar For Induced Infringement
- Cannabis Bill Roundup: NH Lawmakers Mull Home Grow
- Air Force Seeks To Halt Officer's Vax Mandate Suit
- Exec, Son Settle Insider Trading Suit Over COVID Test Deal
- DaVita, Ex-CEO Acquitted In Antitrust No-Poach Trial
- Access Bio, Others Hit Back At $1B 'Windfall' Virus Test Suit
- Albright Maintains Popularity In Early '22 As NPEs Slow Down
- Priest Facing Possible SEC Ban Wants Appeal Heard First
- Time To Fix Legal Industry's Environmental Pro Bono Problem
- Health Hires: CSafe Global, Alumis
- Newborn Opioid Victim Group Says Sackler Releases Justified
- Firm Loses Bid To DQ Atty In Flint Water Crisis Litigation
- Biotech Co. To Pay $4M To End Presentation Hype Suit
- Don't Miss It: Kirkland, Skadden Guide Week's Hot Deals
- Radiology Chain Exec Stiffed Workers In Stock Plan, Suit Says
- Patent Strategy Considerations After Caltech Estoppel Ruling
- 4 Ways Lawyers Keep Busy When Public Markets Are Shut
- Taxation With Representation: Cleary, Simpson Thacher
- Monsanto Judge Pondering $45M Roundup False Ad Deal
- IP Forecast: NetScout To Wrestle With Patent Biz In Texas
- NY Pot Regulators Approve First Adult-Use Grower Licenses
- Zetia Wholesalers Denied Class Cert. In Generics-Delay Suit
- Science Group Sues Homeopathic Co. Over 'Quackery' Drugs
- Changes To Watch In China's Human Genetic Resources Regs
- Biotech Co. Owes NY Tax On Royalties From Foreign Affiliates
- Keller & Heckman Adds Ex-GC From CBD And Tobacco Cos.
- SG Must Take A Stand On Medical Cannabis Reimbursement
- Remembering An Underappreciated Legal Skill — Listening
- Rutgers Students Can't Hide Names In COVID Vaccine Suit
- Ga. Anesthesia Biz Pays $7M To End Kickbacks Case
- Ex-DaVita CEO's 'Feelings' Drove No-Poach Crimes, DOJ Says
- Balwani Jury Can See Theranos' Failed Deals With Military
- Ex-Hospitals Owner Hits Medtronic With $1.3M Clawback Suit
- Report Says McKinsey Hid Conflicts In Advising FDA, Purdue
- DOJ Kickback Concerns Extend Beyond Federal Funds
- Medical Researcher Says DEA Stonewalled Pot Applications
- Attorneys Can Promote Trade, Security Amid Global Conflict
- Cooley Life Sciences IP Team Departs To Mintz Boston Office
- Uncertainty Clouds Attys' Strategies For Pursuing IP In Russia
- 'Vexatious' Ex-MLB Player Abused Court System, Alsup Says
- Cipla Calls Achaogen Claims Over Lost Ch. 11 Sales 'Weak'
- GenapSys Ex-CEO Sues Twice In Del. After Company Fallout
- Drug Cos. Must Face Bulk Of Weight Loss Drug Cancer Suit
- Cleary, Wilson Sonsini Lead GSK's $1.9B Sierra Oncology Buy
- Ex-DaVita CEO Denies Anti-Poach 'Intent' As Feds Rest
- Fresenius GC Says He Was Canned For Flagging Misconduct
- Wash. AG And Distributors Abruptly Shelve Opioid Trial Finale
- Mapping The Top Trials To Know In The Opioid Litigation Wave
- Duane Morris Says Shkreli Owes It $2M In Bid To Drop Client
- Profs Tell Justices Not To Let Courts Decide Int'l Relations
- Merck Escapes False Ad Suit Over Shingles Vaccine
- 11th Circ. Undermined Rare-Disease Drugs, High Court Told
- J&J Must Face Impending Fraud Suit During Talc Unit's Ch. 11
- FDA Bashes Bausch Over Lifetime Talk Show Segment
- COVID-19 Test Supplier Ordered To Return $2M To Retailer
- J&J Unit Trims Mesh False Ad Loss To $302M On Appeal
- Feds Say Holmes' Conviction In Theranos Trial Should Stand
- Fed. Circ. Partly Backs PTAB Bone Graft Patent Decisions
- Teligent OK'd For Fast-Tracked Del. Ch. 11 Disclosure Hearing
- Insurers Want Out Of $16M Medical Device Co. Deal With DOJ
- Walgreens Execs Saw Profit In Opioid Crisis, Fla. Jury Told
- Ex-UChicago Prof Admits Trading On Inside Drug Trial Info
- Fed. Circ. Revives Catheter IP In Fight Against Abbott Unit
- Arthrex Sues For Coverage Of Settled FCA Claims
- The Future Of Legal Ops: Reining In Outside Counsel Costs
- Despite 'Hurt Feelings,' Bid To Intervene In Opioid Deal Denied
- In Surprise Move, Panel Stops Adding Cases To Opioid MDL
- Exec Admits DaVita No-Poach Deal In 'Painful' Testimony
- PTAB To Review Cancer Antibody IP That Drew $41.8M Verdict
- Hemp-Seizing Calif. County Slams Co.'s Illegal Warrant Claim
- Split Fed. Circ. Wipes Roche's $137M IP Loss, Calls For Redo
- Big Pharma Can't Beat SF Opioid Claims Before Trial
- Fed. Circ. Nixes Order Upholding Biogen IP It Also Invalidated
- DC Circ. Denies Hospital's Appeal In Specialty Doctor Pay Row
- When Congress Seeks Cos.' Nonpublic Info From Regulators
- Health Care Is In DOJ's Criminal Antitrust Crosshairs
- Ex-Yankee Stadium Worker Sues Over NYC Vax Rule Carveout
- Biopharm Co. Tarveda To Liquidate In Del. Chancery Court
- 'One Of The Family': Why Trial Attys Love Their Local Counsel
- IPO Outlook Slightly Brightens After A Dismal Start To 2022
- Daiichi Hit With $41.8M Verdict In Cancer Drug IP Fight
- UK Litigation Roundup: Here's What You Missed In London
- Calif. Doc Asks High Court To Review COVID-19 Trial Pause
- Split 5th Circ. Revives Biden's Federal Worker Vax Mandate
- Gilead Says Aetna Must Litigate Its HIV Drug Suit In Fed Court
- IP Forecast: Norton Fights Patent Suit, Armed With New Attys
- Amarin Downplayed Threat Of Vascepa Fight, Investor Says
- Bio-Rad Rival Wants Its COVID Test Tech Cleared Of IP Claims
- PTAB Launches Rare Derivation Review Over Stabilization IP
- Ga. Judge Walks Back Refusal To Toss Wrongful Death Suit
- Bristol-Myers Blood Thinner Patent Invalidated In UK
- Wisconsin Tribe Sues McKinsey Over Role In Opioid Crisis
- In Early Mediation, Negotiate With Empathy, Not Threats
- Animal Hospital Co.'s Bid To End 401(k) Fee Suit Falters
- The USPTO May Be Miscalculating Patent Term Adjustments
- Vanda Wants FDA Info Behind Label Expansion Denial
- ITC Blocks In Vitro Drug Imports Infringing Merck Unit's TM
- Teva Appears Headed For $100M Price-Fixing Payout To AGs
- Fenwick Adds Latham Corporate Atty In Calif.
- Arnold & Porter, 'Dragged Through Mud,' Touts Opioid Probe
- Calif. Naturopathic Doctor Cops To Peddling Fake Vax Cards
- DaVita Rival Felt Threatened Around Poaching, Jury Hears
- Atty Says Failure To Poll Jury In SEC Suit Warrants New Trial
- Balwani Jury Can See Evidence Theranos Used Pharma Logos
- Ruling Favoring Insurers In Opioid Suits May Set Precedent
- China Tariff Clash Leaves Sliver Of Hope For Importers
- US Trustee Urges 2nd Circ. To Reject Sackler Opioid Releases
- Hyman Phelps & McNamara Co-Founder Dies At 83
- Addressing Problematic Drinking In The Legal Profession
- Law Groups Back Suit Over Use Of Henrietta Lacks' Cells
- Rulings, FDA Guidance May Help Food Cos. In Protein Suits
- Cleanup Co. Pays $1.4M To End Wages Claim With NY DOL
- Titan Of The Plaintiffs Bar: Joseph Saveri's Steven Williams
- 'Tomorrow Is A New Day,' Theranos Judge Tells Balwani Atty
- 'Intense Pressure' To Ink Opioid Deal? Too Bad, 6th Circ. Says
- Jackson Addresses Host Of IP Issues In Guarded Comments
- Express Scripts, Mylan Get EpiPen Price Gouging Suit Cut
- Valsartan MDL Judge OKs Out-Of-State Litigants, More Claims
- 7th Circ. Won't Revive False Claims Act Suit Against Safeway
- US Cos. Rebound From Dip In European Patent Applications
- Transforming Law Firms' Diversity Intent Into Real Progress
- Where DOJ Is Heading On Consumer Protection Enforcement
- Pennsylvania CBD Sellers Say Franchiser Cheated Them
- Split 8th Circ. Upholds Dismissal Of Biotech Contract Suit
- Norton Rose Picks Up 11 Blackwell Burke Attys In Minneapolis
- W.Va. AG Blames 3 Opioid Makers As Trial Opens
- Regeneron 'Kickbacks' Boosted Eylea Profits, Insurer Says
- Opioid MDL Judge Cites Miss Piggy To Explain Time Limits
- Teva, Like Glenmark, Rips Expanded Price-Fixing Charges
- Medical Pot Biz Says Ark. Licenses Steered To Big Cos.
- House Approves Bipartisan Medical Marijuana Research Bill
- More Than 20 Law Firms Led Q1's Top 10 Global M&A Deals
- Parts Of Oklahoma PBM Law Invalidated By Judge
- Lab Execs, Texas Hospital Staff Hit With DOJ Kickback Suit
- Gunderson Dettmer Adds Boston Atty As Employment Partner
- Ga. Court Sends Medical Device Patent Dispute To Md.
- Catching Up With Delaware's Chancery Court
- Justices Urged To Scrutinize 'Bad Faith' FCA Defenses
- Sanofi GC Will Sit On 'First-In-Pharma' Diversity Board
- Jury Finds Connecticut Attorney Ran Stock Sale Scheme
- Justices Must Apply Law Evenly In Shadow Docket Rulings
- 'Don't Threaten Me,' Judge Warns Balwani Atty At Fraud Trial
- PureWick Wins $28M Jury Verdict In Catheter Patent Suit
- 9th Circ. Asks Calif. High Court To Decide Shock Therapy Suit
- UK Social Care Biz Receives Possible £821M Takeover Bid
- 11th Circ. Won't Revive False Claims Suit Against HIG Capital
- Vitamin Shoppe Beats Suit Over Muscle Supplements
- Inovio Stockholder Sues In Del. Over COVID Vaccine Claims
- New Horse-Doping Regulator Defeats Constitutional Challenge
- Bayer And J&J Beat FCA Suit Over Antibiotics Claims
- Health Hires: Locke Lord, Essential Pharma
- Tips For Negotiating Litigation Funding Agreements
- Jones Day Snags 3rd Former King & Spalding Atty In Atlanta